ANVS [NYSE]
Annovis Bio, Inc.
Index- P/E- EPS (ttm)-2.15 Insider Own29.50% Shs Outstand8.16M Perf Week-4.99%
Market Cap76.97M Forward P/E- EPS next Y-2.56 Insider Trans0.00% Shs Float5.64M Perf Month-16.14%
Income-17.20M PEG- EPS next Q-0.58 Inst Own15.60% Short Float3.19% Perf Quarter-37.66%
Sales- P/S- EPS this Y-119.40% Inst Trans-14.46% Short Ratio4.63 Perf Half Y-64.23%
Book/sh5.15 P/B1.74 EPS next Y7.60% ROA-36.90% Target Price31.50 Perf Year-81.65%
Cash/sh4.96 P/C1.80 EPS next 5Y- ROE-37.80% 52W Range8.39 - 132.00 Perf YTD-49.15%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-93.23% Beta-
Dividend %- Quick Ratio34.50 Sales past 5Y- Gross Margin- 52W Low6.62% ATR0.87
Employees3 Current Ratio34.50 Sales Q/Q- Oper. Margin- RSI (14)38.37 Volatility7.99% 9.54%
OptionableNo Debt/Eq0.00 EPS Q/Q-56.30% Profit Margin- Rel Volume0.20 Prev Close8.61
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume38.80K Price8.94
Recom1.50 SMA20-8.44% SMA50-24.17% SMA200-58.22% Volume7,667 Change3.83%
Jul-07-21Reiterated Maxim Group Buy $45 → $150
May-05-22 08:55AM  
May-04-22 08:30AM  
Apr-28-22 04:30PM  
Apr-26-22 07:15AM  
Apr-11-22 08:30AM  
Mar-23-22 08:30AM  
Mar-21-22 01:16PM  
Mar-18-22 08:30AM  
Mar-08-22 08:30AM  
Mar-03-22 08:30AM  
Jan-28-22 02:01PM  
Jan-25-22 12:14PM  
09:00AM  
Jan-19-22 04:42AM  
Jan-10-22 08:30AM  
Jan-07-22 12:29PM  
Jan-05-22 08:30AM  
Jan-03-22 08:30AM  
Dec-20-21 08:30AM  
Dec-14-21 08:29AM  
Nov-20-21 06:23AM  
Nov-15-21 09:00AM  
Nov-12-21 10:26AM  
Nov-09-21 08:30AM  
Nov-03-21 10:43AM  
Nov-02-21 08:30AM  
Oct-18-21 08:10AM  
07:00AM  
Oct-15-21 09:00PM  
08:56PM  
04:21PM  
01:42PM  
08:15AM  
Oct-14-21 07:10PM  
04:20PM  
01:11PM  
08:15AM  
06:13AM  
Oct-13-21 10:00PM  
03:30PM  
12:00PM  
11:00AM  
11:00AM  
10:45AM  
10:20AM  
08:49AM  
08:30AM  
Oct-12-21 10:49PM  
09:06PM  
08:10PM  
06:40PM  
05:28PM  
04:30PM  
04:30PM  
03:37PM  
03:10PM  
03:03PM  
01:38PM  
12:45PM  
12:15PM  
09:20AM  
08:30AM  
06:28AM  
05:40AM  
Oct-11-21 11:55PM  
10:47PM  
06:17PM  
05:15PM  
04:25PM  
04:15PM  
03:25PM  
11:13AM  
11:00AM  
09:34AM  
09:15AM  
09:08AM  
08:35AM  
05:26AM  
Oct-10-21 09:00PM  
04:07PM  
10:35AM  
Oct-09-21 06:05PM  
04:28PM  
10:22AM  
10:15AM  
Oct-08-21 11:45PM  
10:50PM  
07:19PM  
05:04PM  
04:45PM  
03:00PM  
02:30PM  
01:00PM  
11:55AM  
11:00AM  
09:14AM  
07:45AM  
05:30AM  
Oct-07-21 10:50PM  
10:00PM  
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maccecchini Maria-LuisaPresident and CEOJan 14Option Exercise0.1432,9594,614987,734Jan 18 09:08 PM
Hoffman Michael BDirectorJan 04Option Exercise3.5937,142133,4861,416,373Jan 05 07:41 PM
White Mark K.DirectorOct 12Buy27.405,000137,00056,177Oct 13 04:02 PM
Bruck ClaudineDirectorOct 11Buy27.661815,0066,067Oct 13 04:03 PM
Maccecchini Maria-LuisaPRESIDENT AND CEOOct 11Buy27.6118,000496,980976,775Oct 13 04:00 PM
McCarthy ReidDirectorAug 19Buy37.6150018,8056,829Aug 23 11:36 AM